Avalo Therapeutics (AVTX) Enterprise Value Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Avalo Therapeutics | 317.29 Mn | 317.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 54.30% |
| Dec 31, 2025 | 38.67% |
| Sep 30, 2025 | -3.53% |
| Jun 30, 2025 | 24.01% |
| Mar 31, 2025 | -13.50% |
| Dec 31, 2024 | -13,454,500.00% |
| Sep 30, 2024 | -8,185,700.00% |
| Jun 30, 2024 | -622,740.00% |
| Mar 31, 2024 | -560.26% |
| Dec 31, 2023 | 93.33% |
| Sep 30, 2023 | 99.99% |
| Jun 30, 2023 | -7.14% |
| Mar 31, 2023 | -16,587.00% |
| Dec 31, 2022 | 99.97% |
| Sep 30, 2022 | 76.31% |
| Jun 30, 2022 | 99.97% |
| Mar 31, 2022 | 99.74% |
| Dec 31, 2021 | -143,544.74% |
| Sep 30, 2021 | -54,071.21% |
| Jun 30, 2021 | -122,430.30% |
| Mar 31, 2021 | -159.19% |
| Dec 31, 2020 | 99.50% |
| Sep 30, 2020 | -29.14% |
| Jun 30, 2020 | 99.65% |
| Mar 31, 2020 | 8.36% |
| Dec 31, 2019 | -40,724.78% |
| Sep 30, 2019 | -176.05% |
| Jun 30, 2019 | -330.63% |
| Mar 31, 2019 | -538.74% |
| Dec 31, 2018 | 99.28% |
| Sep 30, 2018 | 99.85% |
| Jun 30, 2018 | -16,289.29% |
| Mar 31, 2018 | 15.91% |
| Dec 31, 2017 | 49.91% |
| Sep 30, 2017 | -171.75% |
| Jun 30, 2017 | 99.89% |
| Mar 31, 2017 | 81.92% |
| Dec 31, 2016 | 75.42% |
| Sep 30, 2016 | -166.48% |
| Jun 30, 2016 | -93.39% |
| Mar 31, 2016 | -91.76% |
| Dec 31, 2015 | -80.22% |
| Sep 30, 2015 | 78.97% |